Latest News

  • ANUGERAH KARYA CIPTA DOKTER INDONESIA: Kalbe and IDI Appreciate Research Doctors

    Tuesday, September 28, 2021
    ANUGERAH KARYA CIPTA DOKTER INDONESIA:  Kalbe and IDI Appreciate Research Doctors

    Jakarta, September 28, 2021, the Research Institute for the Indonesian Doctors Association (IDI) and PT Kalbe Farma Tbk (Kalbe) for the third time is holding the Anugerah Karya Cipta Dokter Indonesia (AKCDI IDI-KALBE) program, a program created to present awards to Indonesian Doctors who have conducted dedicated researches and have worked hard in producing research work in the health field. This program is a continuation of Kalbe's collaboration with the IDI Research Institute to develop health-based researches, especially by doctors in Indonesia.

  • KALBE AND KOMPAS GRAMEDIA SUPPORT ACCELERATION OF VACCINATION OF PEOPLE OF BANDUNG REGENCY

    Tuesday, September 14, 2021
    KALBE AND KOMPAS GRAMEDIA SUPPORT ACCELERATION OF VACCINATION OF PEOPLE OF BANDUNG REGENCY

    Bandung, September 14, 2021. PT Kalbe Farma Tbk (Kalbe) and Kompas Gramedia (KG) in collaboration with Kodam III/Siliwangi and the Bandung Regency Government today organized a COVID-19 Vaccination Center at Dome Balerame, Sabilulungan Cultural Area, Soreang. This vaccination center targets pregnant women, students, and the general public. This COVID-19 vaccination center is a series of follow-up programs "Rise for Freedom from COVID-19" from the City of Jakarta, Pekanbaru City, Gresik Regency, and also Bantul Regency.

  • KALBE EDUCATION BRAIN FOG ALERT AS A LONG TERM EFFECT POST COVID-19

    Wednesday, August 18, 2021
    KALBE EDUCATION BRAIN FOG ALERT AS A LONG TERM EFFECT POST COVID-19

    Jakarta, August 18, 2021, PT Kalbe Farma Tbk (Kalbe) held an online health education event with the media with the theme “Beware of Brain Fog As a Long-Term Effect of Post-COVID-19, which featured the speakers Dr. dr. Yuda Turana, Sp.S – Neurologist Atmajaya Hospital (Counselor – ALZI/Alzheimer Indonesia) and Nandhita Octavia Nugriani, S.T., B.Eng – Product Management PT Kalbe Farma Tbk. This education aims to provide information to the public about the symptoms of Brain Fog as a long-covid phenomenon after recovering from a COVID-19 infection, socializing how Brain Fog can occur, the possible dangers, and how to get treatment tips to prevent these symptoms from becoming one of the risks of early-onset dementia as well as introducing the health supplement Citicoline (Brainact Odis®) which functions to help Brain Fog therapy with safe side effects, fresh taste, and the benefit of it being quickly dissolved in the mouth without the need for drinking water (practical).

  • TARGETING PREGNANT WOMEN, KALBE COLLABORATES WITH KG AND BKKBN HOLDS VACCINATION CENTER "Rise for Independence from COVID-19"

    Tuesday, August 17, 2021
    TARGETING PREGNANT WOMEN, KALBE COLLABORATES WITH KG AND BKKBN  HOLDS VACCINATION CENTER "Rise for Independence from COVID-19"
    Jakarta, August 17, 2021.  PT Kalbe Farma Tbk (“Kalbe”).   Pregnant women are one of the groups with the highest risk if exposed to COVID-19.  The Ministry of Health has issued Circular HK.02.01/I/2007/2021 regarding COVID-19 Vaccination for Pregnant Women.  For this reason, Kalbe collaborated with Kompas Gramedia, the National Population and Family Planning Agency (BKKBN), the Indonesian Obstetrics and Gynecology Association (POGI), and the Indonesian Midwives Association (IBI) to organize the opening of the Covid-19 Vaccination Center for the public that specifically targets pregnant women.
RSS
12345Last